We assessed expression of P2X7 receptor in ovarian cancer cell lines and tissues by immunocytochemistry and immunohistochemistry using a commercially available polyclonal antibody from Novus Biologicals (NBP2‐19654). This evidence concerns the gene P2RX7 and ovarian cancer.